Product Launch Announcement: Sorafemax 200 (Sorafenib 200mg) Tablet
We are proud to introduce Sorafemax 200 is a prescription oral anticancer medication containing Sorafenib 200mg, a well-established multikinase inhibitor used in the management of specific advanced cancers. Designed to inhibit tumor cell proliferation and angiogenesis, Sorafemax 200 (Sorafenib 200mg) plays a critical role in targeted cancer therapy. The formulation ensures consistent dosing, quality, and therapeutic reliability for long-term treatment protocols.
🔍 Product Overview
Generic Name: Sorafenib
Strength: 200mg
Formulation: Oral Tablet
Primary Indications:
Sorafemax 200 – Sorafenib 200mg Tablet are indicated for the treatment of:
- Advanced Renal Cell Carcinoma (RCC)
- Unresectable or Advanced Hepatocellular Carcinoma (HCC)
- Progressive Differentiated Thyroid Carcinoma (DTC), Locally Recurrent or Metastatic that is refractory to radioactive iodine treatment.
Mechanism of Action:
Sorafemax 200 – Sorafenib 200mg Tablet is a multikinase inhibitor that targets both tumor cell proliferation and tumor angiogenesis. It acts by inhibiting:
- RAF kinases, interrupting tumor cell signaling pathways involved in cancer cell growth
- Receptor tyrosine kinases including VEGFR and PDGFR, which play a critical role in tumor blood vessel formation
By simultaneously blocking these pathways, Sorafenib helps slow tumor progression and reduce the development of new blood vessels that support cancer growth.
💡 Key Benefits
· Targeted Therapy: Inhibits multiple kinases involved in tumor growth and blood vessel formation
· Clinically Proven Molecule: Sorafenib is supported by extensive global clinical data
· Oral Convenience: Tablet dosage form allows ease of administration and better patient compliance
· Consistent Quality: Manufactured under stringent quality standards to ensure safety and efficacy
· Trusted Treatment Option: Widely used in oncology practice worldwide
🎯 Target Audience
- Oncologists & Cancer Specialists
- Hospitals and Oncology Centers
- Pharmacies and Specialty Drug Distributors
- Healthcare Institutions managing advanced cancer therapies
🏥 Commitment to Clinical Excellence
At the core of Sorafemax 200 (Sorafenib 200mg) is an unwavering commitment to clinical excellence and patient safety. Each tablet is produced in compliance with international pharmaceutical quality guidelines, ensuring purity, stability, and therapeutic performance. Continuous quality monitoring and adherence to regulatory standards reflect our dedication to supporting healthcare professionals with dependable oncology solutions.
📦 Availability
Sorafemax 200 (Sorafenib 200 mg) Tablets are available through authorized distributors and healthcare channels. For supply inquiries, bulk orders, or regulatory documentation, please contact our sales or distribution team.
Sorafemax 200 – Targeted Sorafenib Therapy You Can Trust
